Hepatic encephalopathy is a liver disease that affects the brain. Learn how a new treatment can treat the disease and prevent ...

Robust microbiome signatures enable more precise diagnoses and open up new therapeutic approaches for the treatment of NAFLD ...

Nonalcoholic fatty liver disease (NAFLD) affects up to 40% of the population in western countries and is one of the most ...

The gut–liver axis is of crucial importance in health and disease. TM6SF2 is a genetic risk factor for metabolic dysfunction-associated steatotic liver disease. Zhang, Yu et al. reveal that ...

The review discusses the gut-liver axis as an important pathway in the development of ALD. Alcohol-induced changes in gut microbiota, known as dysbiosis, can increase intestinal permeability ...

Further clinical research is needed to investigate this gut–liver–brain axis as a target for therapies that may help manage metabolic diseases, the authors note. More information: Tingting ...